HQ

Clinical Trials

Clinical study information and updates

PharmaEssentia is committed to scientific excellence in its ongoing clinical research. We are deeply appreciative of the study sites, investigators, patients, caregivers, and clinicians who support our efforts through their participation.

Learn more about our clinical trials

Essential Thrombocythemia

PharmaEssentia is now enrolling for a Phase 3 clinical research study in the U.S. for people with Essential Thrombocythemia (ET). For more information, please visit www.SurpassET.com or visit www.ClinicalTrials.gov (NCT04285086).